Primary pericardial angiosarcoma: case report and review of treatment options.

angiosarcoma cardiac tumour

Journal

Ecancermedicalscience
ISSN: 1754-6605
Titre abrégé: Ecancermedicalscience
Pays: England
ID NLM: 101392236

Informations de publication

Date de publication:
2020
Historique:
received: 03 03 2020
entrez: 26 6 2020
pubmed: 26 6 2020
medline: 26 6 2020
Statut: epublish

Résumé

A primary cardiac angiosarcoma is a rare type of soft-tissue sarcoma with a high mortality rate. This report describes a young woman who presented with chest pain and worsening shortness of breath over the course of a year. She was diagnosed with and treated for latent tuberculosis and autoimmune pericarditis over the last year, however, her condition kept worsening. Further workup revealed a large pericardial and right atrial mass associated with multiple lung nodules. The biopsy from the lung mass showed angiosarcoma, and she was diagnosed with primary metastatic angiosarcoma of the pericardium. She was treated with doxorubicin and Ifosfamide (AIM-75 regimen), which led to a partial response. However, soon after completion of six cycles, the tumour progressed rapidly, leading to cardio-respiratory failure. In this report, we will discuss the clinical challenges and treatment options (surgical and medical) that are available for treating patients with angiosarcoma of the heart.

Identifiants

pubmed: 32582371
doi: 10.3332/ecancer.2020.1056
pii: can-14-1056
pmc: PMC7302885
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1056

Informations de copyright

© the authors; licensee ecancermedicalscience.

Déclaration de conflit d'intérêts

The authors do not have any conflicts of interest to declare.

Références

Ann Surg Oncol. 2009 Dec;16(12):3358-65
pubmed: 19830494
J Heart Lung Transplant. 2002 Oct;21(10):1135-9
pubmed: 12398881
Lancet Oncol. 2017 Nov;18(11):1493-1501
pubmed: 28988646
Lancet Oncol. 2018 Mar;19(3):416-426
pubmed: 29370992
Ann Thorac Surg. 2019 Apr;107(4):1126-1131
pubmed: 30471276
Ann Thorac Surg. 2017 Jul;104(1):90-96
pubmed: 28189277
Ann Thorac Surg. 2010 Jul;90(1):176-81
pubmed: 20609770
Oncologist. 2005 Nov-Dec;10(10):833-41
pubmed: 16314294
Br J Cancer. 1998 Dec;78(12):1624-8
pubmed: 9862574
Sarcoma. 2015;2015:532478
pubmed: 26074722
J Immunother Cancer. 2017 Jul 18;5(1):58
pubmed: 28716069
Gen Thorac Cardiovasc Surg. 2018 May;66(5):257-262
pubmed: 29594875
Ann Thorac Surg. 2014 Sep;98(3):863-8
pubmed: 25086947
J Thorac Cardiovasc Surg. 2009 Jun;137(6):1454-60
pubmed: 19464464
Br J Dermatol. 2018 Aug;179(2):530-531
pubmed: 29700818
Gen Thorac Cardiovasc Surg. 2013 Aug;61(8):435-47
pubmed: 23460447
Tex Heart Inst J. 2011;38(3):261-2
pubmed: 21720466
Oncologist. 2007 Sep;12(9):1134-42
pubmed: 17914083
Lancet Oncol. 2010 Oct;11(10):983-91
pubmed: 20537949
Cancer. 2008 Jun;112(11):2440-6
pubmed: 18428209
Ann Thorac Surg. 2006 Aug;82(2):645-50
pubmed: 16863779

Auteurs

Udit Yadav (U)

Department of Medicine, Division of Hematology and Oncology, John H Stroger, Jr Hospital of Cook County, Chicago, IL, USA.

Ankit Mangla (A)

Department of Hematology and Oncology, Case Western University School of Medicine, Cleveland, OH, USA.

Classifications MeSH